In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate

Frances L. Clouse, Laurie B. Hovde, John C Rotschafer

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

This study compared the ability of telavancin to the ability of cefazolin and vancomycin to eliminate staphylococci from peritoneal dialysis fluid by using a static in vitro model to simulate the conditions of peritoneal dialysis. The results showed that telavancin exhibited statistically significantly better kill (P < 0.05) against both methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Original languageEnglish (US)
Pages (from-to)4521-4524
Number of pages4
JournalAntimicrobial agents and chemotherapy
Volume51
Issue number12
DOIs
StatePublished - Dec 2007

Fingerprint

Dive into the research topics of 'In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate'. Together they form a unique fingerprint.

Cite this